Urodie en es it fr

Urodie Brand names, Urodie Analogs

Urodie Brand Names Mixture

  • No information avaliable

Urodie Chemical_Formula


Urodie RX_link


Urodie fda sheet

Urodie FDA

Urodie msds (material safety sheet)

Urodie Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Urodie Molecular Weight

387.433 g/mol

Urodie Melting Point

273 oC

Urodie H2O Solubility


Urodie State


Urodie LogP


Urodie Dosage Forms


Urodie Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Urodie Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Urodie Absorption

Essentially completely absorbed in man (90% bioavailability).

Urodie side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Urodie Patient Information

Urodie Organisms Affected

Humans and other mammals